TolerUp Enteral Feeding Protocol

NCT ID: NCT03648255

Last Updated: 2020-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

133 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-02-19

Study Completion Date

2020-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, observational, multi-center study will follow children with cerebral palsy who decided to switch to an enteral product that contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Tolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of cerebral palsy
* Fed with an enteral product that does not contain partially hydrolyzed protein and medium chain triglycerides and decided to be switched to an enteral product contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance
* Fed by tube, using enteral tube feeding as sole source of nutrition
* A signed and dated informed consent by subject's legally acceptable representative

Exclusion Criteria

* Chronic diseases other than cerebral palsy (e.g. diabetes mellitus, renal, liver, endocrine diseases, malignancy)
* Intestinal obstruction
* Dialysis treatment
* Requirement of artificial ventilation
* Requirement of parenteral nutrition
* Normal nutrition in addition to enteral tube feeding
* Allergy or intolerance to any ingredient of the study product
* Currently participating in another clinical or non-clinical study
Minimum Eligible Age

1 Year

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Nutrition

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aysugül Alptekin, MD

Role: STUDY_CHAIR

Abbott Turkey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Çukurova University Medical Faculty

Adana, , Turkey (Türkiye)

Site Status

Hacettepe Üniversitesi University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Ankara Dışkapı Child Disease Hospital

Ankara, , Turkey (Türkiye)

Site Status

Gazi University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Ankara University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Bursa Yüksek İhtisas Research and Training Hospital

Bursa, , Turkey (Türkiye)

Site Status

Pamukkale Üniversitesi University Medical Faculty

Denizli, , Turkey (Türkiye)

Site Status

Elazığ University Medical Faculty

Elâzığ, , Turkey (Türkiye)

Site Status

Eskişehir Osmangazi University Medical Faculty

Eskişehir, , Turkey (Türkiye)

Site Status

Koç University Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

İstanbul Kanuni Sultan Süleyman Research and Training Hospital

Istanbul, , Turkey (Türkiye)

Site Status

İstanbul Şişli Hamidiye Etfal Research and Training Hospital

Istanbul, , Turkey (Türkiye)

Site Status

İstanbul Ümraniye Research and Training Hospital

Istanbul, , Turkey (Türkiye)

Site Status

İzmir Behçet Uz Child Disease Hospital

Izmir, , Turkey (Türkiye)

Site Status

Kocaeli Üniversitesi University Medical Faculty

Kocaeli, , Turkey (Türkiye)

Site Status

Kırıkkale University Medical Faculty

Kırıkkale, , Turkey (Türkiye)

Site Status

İnönü Üniversitesi University Medical Faculty

Malatya, , Turkey (Türkiye)

Site Status

Ondokuz Mayıs University Medical Faculty

Samsun, , Turkey (Türkiye)

Site Status

Karadeniz Teknik University Medical Faculty

Trabzon, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DA15

Identifier Type: -

Identifier Source: org_study_id